Deutsche Bank
COGT icon

Deutsche Bank’s Cogent Biosciences COGT Stock Holding History

Deutsche Bank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.91M Buy
127,469
+18,341
+17% +$677K ﹤0.01% 1302
2025
Q4 		$3.88M Buy
109,128
+13,001
+14% +$365K ﹤0.01% 1433
2025
Q3 		$1.38M Buy
96,127
+38,397
+67% +$455K ﹤0.01% 1985
2025
Q2 		$415K Sell
57,730
-13,167
-19% -$73K ﹤0.01% 2547
2025
Q1 		$425K Sell
70,897
-8,368
-11% -$65.6K ﹤0.01% 2567
2024
Q4 		$618K Sell
79,265
-83,593
-51% -$833K ﹤0.01% 2501
2024
Q3 		$1.76M Sell
162,858
-75,582
-32% -$736K ﹤0.01% 1834
2024
Q2 		$2.01M Sell
238,440
-486
-0.2% -$3.69K ﹤0.01% 1632
2024
Q1 		$1.61M Buy
238,926
+201,491
+538% +$1.25M ﹤0.01% 1770
2023
Q4 		$220K Sell
37,435
-599
-2% -$4.59K ﹤0.01% 2829
2023
Q3 		$371K Buy
38,034
+9,106
+31% +$108K ﹤0.01% 2361
2023
Q2 		$343K Sell
28,928
-14,971
-34% -$172K ﹤0.01% 2575
2023
Q1 		$474K Buy
43,899
+8,628
+24% +$110K ﹤0.01% 2528
2022
Q4 		$408K Buy
35,271
+8,456
+32% +$105K ﹤0.01% 2559
2022
Q3 		$400K Buy
26,815
+5,725
+27% +$78.5K ﹤0.01% 2504
2022
Q2 		$190K Buy
21,090
+913
+5% +$6.23K ﹤0.01% 3207
2022
Q1 		$151K Sell
20,177
-2,398
-11% -$16.7K ﹤0.01% 3412
2021
Q4 		$194K Buy
22,575
+1,202
+6% +$10.4K ﹤0.01% 3404
2021
Q3 		$180K Sell
21,373
-687
-3% -$5.26K ﹤0.01% 3620
2021
Q2 		$179K Buy
+22,060
New +$186K ﹤0.01% 3846
2020
Q1 		– Sell
-2,433
Closed -$7K – 4400
2019
Q4 		$7K Buy
2,433
+2,258
+1,290% +$9.22K ﹤0.01% 4577
2019
Q3 		$1K Sell
175
-7,170
-98% -$58.3K ﹤0.01% 4802
2019
Q2 		$75K Sell
7,345
-15,071
-67% -$201K ﹤0.01% 4340
2019
Q1 		$391K Buy
22,416
+6,502
+41% +$111K ﹤0.01% 3597
2018
Q4 		$279K Buy
15,914
+6,452
+68% +$191K ﹤0.01% 3687
2018
Q3 		$389K Buy
9,462
+7,364
+351% +$415K ﹤0.01% 3915
2018
Q2 		$120K Buy
+2,098
New +$101K ﹤0.01% 4481

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Deutsche Bank's COGT Position: Q1 2026 in Review

Deutsche Bank increased its Cogent Biosciences (COGT) stake by 17% in Q1 2026, buying an estimated $677K and bringing the position to 127,469 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

Deutsche Bank first reported a position in COGT in Q2 2018 and has held it in 27 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Deutsche Bank held 127,469 shares of Cogent Biosciences worth $4.91M as of Q1 2026.
  • Deutsche Bank bought 18,341 Cogent Biosciences shares in Q1 2026, an estimated $677K.
  • Cogent Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1302 holding.
  • Deutsche Bank first reported a position in Cogent Biosciences in Q2 2018 and has held it in 27 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.